Akzo Nobel N.V.
AKZOF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $10,711 | $10,668 | $10,846 | $9,587 |
| % Growth | 0.4% | -1.6% | 13.1% | – |
| Cost of Goods Sold | $6,374 | $6,434 | $6,923 | $5,732 |
| Gross Profit | $4,337 | $4,234 | $3,923 | $3,855 |
| % Margin | 40.5% | 39.7% | 36.2% | 40.2% |
| R&D Expenses | $0 | $270 | $258 | $230 |
| G&A Expenses | $323 | $328 | $338 | $276 |
| SG&A Expenses | $1,563 | $1,538 | $1,531 | $1,296 |
| Sales & Mktg Exp. | $1,240 | $1,210 | $1,193 | $1,020 |
| Other Operating Expenses | $1,857 | $1,397 | $1,426 | $1,211 |
| Operating Expenses | $3,420 | $3,205 | $3,215 | $2,737 |
| Operating Income | $917 | $1,029 | $708 | $1,118 |
| % Margin | 8.6% | 9.6% | 6.5% | 11.7% |
| Other Income/Exp. Net | -$79 | -$245 | -$106 | -$13 |
| Pre-Tax Income | $838 | $784 | $602 | $1,105 |
| Tax Expense | $246 | $296 | $214 | $246 |
| Net Income | $542 | $442 | $352 | $829 |
| % Margin | 5.1% | 4.1% | 3.2% | 8.6% |
| EPS | 3.17 | 2.61 | 2.01 | 4.48 |
| % Growth | 21.5% | 29.9% | -55.1% | – |
| EPS Diluted | 3.16 | 2.58 | 2.01 | 4.46 |
| Weighted Avg Shares Out | 171 | 169 | 175 | 185 |
| Weighted Avg Shares Out Dil | 172 | 171 | 175 | 186 |
| Supplemental Information | – | – | – | – |
| Interest Income | $88 | $95 | $54 | $35 |
| Interest Expense | $190 | $193 | $106 | $74 |
| Depreciation & Amortization | $371 | $258 | $362 | $351 |
| EBITDA | $1,399 | $1,320 | $1,070 | $1,530 |
| % Margin | 13.1% | 12.4% | 9.9% | 16% |